AIO-mCherry Citations (8)

Originally described in: CRISPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to enhance genome editing.
Chiang TW, le Sage C, Larrieu D, Demir M, Jackson SP Sci Rep. 2016 Apr 15;6:24356. doi: 10.1038/srep24356. PubMed Journal

---

Articles Citing AIO-mCherry

Articles
[A Plasmid-Expressed CRISPR/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture]. Karpov DS, Karpov VL, Klimova RR, Demidova NA, Kushch AA. Mol Biol (Mosk). 2019 Jan-Feb;53(1):91-100. doi: 10.1134/S0026898419010051. PubMed
Gradual compaction of the central spindle decreases its dynamicity in PRC1 and EB1 gene-edited cells. Asthana J, Cade NI, Normanno D, Lim WM, Surrey T. Life Sci Alliance. 2021 Sep 27;4(12). pii: 4/12/e202101222. doi: 10.26508/lsa.202101222. Print 2021 Dec. PubMed
Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA. Leal AF, Almeciga-Diaz CJ. Gene Ther. 2022 May 18. pii: 10.1038/s41434-022-00344-3. doi: 10.1038/s41434-022-00344-3. PubMed
Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based nanoparticles. Leal AF, Cifuentes J, Torres CE, Suarez D, Quezada V, Gomez SC, Cruz JC, Reyes LH, Espejo-Mojica AJ, Almeciga-Diaz CJ. Sci Rep. 2022 Sep 3;12(1):15045. doi: 10.1038/s41598-022-19407-x. PubMed
CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors. Leal AF, Cifuentes J, Quezada V, Benincore-Florez E, Cruz JC, Reyes LH, Espejo-Mojica AJ, Almeciga-Diaz CJ. Int J Mol Sci. 2022 Sep 14;23(18):10672. doi: 10.3390/ijms231810672. PubMed
Development of super-specific epigenome editing by targeted allele-specific DNA methylation. Rajaram N, Kouroukli AG, Bens S, Bashtrykov P, Jeltsch A. Epigenetics Chromatin. 2023 Oct 21;16(1):41. doi: 10.1186/s13072-023-00515-5. PubMed
Iron oxide-coupled CRISPR-nCas9-based genome editing assessment in mucopolysaccharidosis IVA mice. Leal AF, Celik B, Fnu N, Khan S, Tomatsu S, Almeciga-Diaz CJ. Mol Ther Methods Clin Dev. 2023 Nov 7;31:101153. doi: 10.1016/j.omtm.2023.101153. eCollection 2023 Dec 14. PubMed
CHD6 has poly(ADP-ribose)- and DNA-binding domains and regulates PARP1/2-trapping inhibitor sensitivity via abasic site repair. Provencher L, Nartey W, Brownlee PM, Atkins AW, Gagne JP, Baudrier L, Ting NSY, Piett CG, Fang S, Pearson DD, Moore S, Billon P, Nagel ZD, Poirier GG, Williams GJ, Goodarzi AA. Nat Commun. 2025 Jan 25;16(1):1026. doi: 10.1038/s41467-025-56085-5. PubMed

If you have published an article using this material, please email us at to have your article added to this page.